Treatment of ADHD in prison inmates


Dr Ylva Ginsberg and colleagues recently conducted a study to test the effectiveness of methylphenidate as a treatment for ADHD in prison inmates. Here, Dr Ginsberg discusses her findings with Dr Ovais Badat, and reviews how the research can influence future treatment in prison populations.


Date published: 13 March 2012

Presenter: Dr Ovais Badat

Interviewee: Dr Ylva Ginsberg

Audio running time: 15 minutes

Credits: 0.5


Learning outcomes


By the end of this podcast, we hope you will have gained an understanding of:


  • the prevalence of ADHD in prison inmates


  • the background of and reasons for this particular study


  • the effectiveness of osmotic-release oral system (OROS) methylphenidate as a treatment for male long-term prison inmates with ADHD


  • how this study has altered practice in the Swedish prison and probation service


  • how the findings can help with research and clinical practice in the future.


Take the module test and gain CPD certification


Please note: This podcast was recorded in 2012. Please be aware that some of the material covered and/or guidance may have changed.
Having problems downloading or playing the podcast file? View our troubleshooting page.


If you like this podcast, you may also be interested in the following:


Assessing and communicating violence risk by Dr Mike Doyle


Neurobiology of ADHD by Dr Katia Rubia


Rehabilitation psychiatry: principles and practice by Dr Frank Holloway

© 2021 Royal College of Psychiatrists